Mp75-09 How Nocturia Can Help a Urologist Diagnose a Sleep Disorder

You have accessJournal of UrologyUrodynamics/Lower Urinary Tract Dysfunction/Female Pelvic Medicine: Non-neurogenic Voiding Dysfunction (Excluding OAB) (MP75)1 May 2024MP75-09 HOW NOCTURIA CAN HELP A UROLOGIST DIAGNOSE A SLEEP DISORDER Frederick P. Kudlata, Om Sakhalkar, Luke Scanlan, Matthew N. Simmons, Martha K. Terris, and Pablo Santamaria Frederick P. KudlataFrederick P. Kudlata , Om SakhalkarOm Sakhalkar , Luke ScanlanLuke Scanlan , Matthew N. SimmonsMatthew N. Simmons , Martha K. TerrisMartha K. Terris , and Pablo SantamariaPablo Santamaria View All Author Informationhttps://doi.org/10.1097/01.JU.0001008676.21744.5f.09AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVE: There is a well-established association between obstructive sleep apnea (OSA) and nocturia. However, it is not common practice for nocturia patients to receive a complete workup for underlying OSA. The majority of patients who present to the urology clinic at our institution with nocturia (defined as more than twice per night) are referred for an at-home sleep study. Our goal is to assess whether nocturia patients are being adequately evaluated for OSA and to analyze the effect of continuous or automatic positive airway pressure (CPAP/APAP) therapy on nocturia symptom severity. METHODS: We conducted a retrospective chart review of all patients diagnosed with nocturia who completed an at-home sleep study for OSA at our institution between July 2020 and September 2023. Patients with a pre-existing OSA diagnosis and female patients were excluded from this study. Statistical analysis included univariate regression models and paired t-tests. RESULTS: More than 300 nocturia patients were referred for an at-home sleep study, but only 37 patients completed the study. All 37 (100%) of those patients met diagnosis criteria for OSA. Of the 37, 16 patients (43.2%) initiated CPAP/APAP therapy. For the patients concurrently receiving medical management for nocturia, there was a significant difference (p<.01) between the mean number of nocturic episodes before (3.58; SD=1.10) and after (2.38; SD=.83) CPAP/APAP. Before any CPAP/APAP therapy, there was no significant difference between the mean number of nocturic episodes before (4.33; SD=.71) and after (3.44; SD=1.01) initiation of medical management for nocturia (p=.052; Table 1). Of the 16 patients who initiated CPAP/APAP therapy, 12 patients reported subjective improvements in lower urinary tract symptoms (LUTS), 2 patients reported no perceived improvement in LUTS, and 2 patients did not comment on the matter. CONCLUSIONS: All nocturia patients who completed a sleep study were diagnosed with OSA. Yet, most nocturia patients did not follow up with the sleep study referral, suggesting a potential underdiagnosis and undertreatment of nocturia comorbidities. For patients with nocturia and OSA, medical management and CPAP/APAP therapy might decrease nocturia symptoms and increase patient satisfaction. Source of Funding: None © 2024 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 211Issue 5SMay 2024Page: e1235 Advertisement Copyright & Permissions© 2024 by American Urological Association Education and Research, Inc.Metrics Author Information Frederick P. Kudlata More articles by this author Om Sakhalkar More articles by this author Luke Scanlan More articles by this author Matthew N. Simmons More articles by this author Martha K. Terris More articles by this author Pablo Santamaria More articles by this author Expand All Advertisement PDF downloadLoading ...